$259 Million is the total value of Iron Triangle Partners LP's 26 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 366.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| EHC | Buy | ENCOMPASS HEALTH CORP | $25,612,000 | -6.8% | 400,000 | +0.8% | 9.91% | +36.0% |
| HZNP | Buy | HORIZON THERAPEUTICS PUB LTD | $14,810,000 | -16.2% | 500,000 | +2.4% | 5.73% | +22.3% |
| NVRO | Buy | NEVRO CORP | $13,997,000 | +33.3% | 140,000 | +56.7% | 5.41% | +94.5% |
| MOH | New | MOLINA HEALTHCARE INC | $13,007,000 | – | 93,097 | +100.0% | 5.03% | – |
| CRL | New | CHARLES RIV LABS INTL INC | $12,621,000 | – | 100,000 | +100.0% | 4.88% | – |
| CHNG | New | CHANGE HEALTHCARE INC | $11,606,000 | – | 1,161,713 | +100.0% | 4.49% | – |
| CTLT | New | CATALENT INC | $10,390,000 | – | 200,000 | +100.0% | 4.02% | – |
| ABC | New | AMERISOURCEBERGEN CORP | $9,735,000 | – | 110,000 | +100.0% | 3.77% | – |
| TEVA | New | TEVA PHARMACEUTICAL INDS LTDsponsored ads | $8,980,000 | – | 1,000,000 | +100.0% | 3.47% | – |
| BAX | New | BAXTER INTL INC | $8,119,000 | – | 100,000 | +100.0% | 3.14% | – |
| SDGR | New | SCHRODINGER INC | $6,468,000 | – | 150,000 | +100.0% | 2.50% | – |
| HRTX | New | HERON THERAPEUTICS INC | $5,870,000 | – | 500,000 | +100.0% | 2.27% | – |
| AXNX | New | AXONICS MODULATION TECHNOLOG | $5,082,000 | – | 200,000 | +100.0% | 1.97% | – |
| BKD | New | BROOKDALE SR LIVING INC | $4,680,000 | – | 1,500,000 | +100.0% | 1.81% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HORIZON THERAPEUTICS PUB LTD | 12 | Q3 2022 | 9.0% |
| GUARDANT HEALTH INC | 12 | Q3 2022 | 6.1% |
| CHARLES RIV LABS INTL INC | 11 | Q1 2023 | 7.8% |
| SURGERY PARTNERS INC | 11 | Q2 2023 | 6.4% |
| ICON PLC | 10 | Q3 2023 | 11.7% |
| BOSTON SCIENTIFIC CORP | 10 | Q3 2023 | 8.9% |
| NEVRO CORP | 10 | Q1 2022 | 6.7% |
| DEXCOM INC | 10 | Q3 2023 | 7.7% |
| ABBVIE INC | 9 | Q3 2023 | 8.1% |
| ACADIA HEALTHCARE COMPANY IN | 9 | Q3 2023 | 7.9% |
View Iron Triangle Partners LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View Iron Triangle Partners LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.